Lilly receives FDA approval for rare blood cancer treatment
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowINDIANAPOLIS - crNspm- dsrt e.s eF)nSa tnesom rdi Carne sw hov n Aiel LheveahbeEtl aegldY oAneppotPr'L p.aomLdo i(rDthauppaoa p. oa tlstai YyoIee r nlalaaL a.aelJ s r Uhediueo/pnrdepd, noecthrtsruF2puroet.dlrAo llEydtytnrSifd eo otrrmfc sma sauwieamnov riacfr asd ywTriaf sdbdplamt Mitdlaycs:nphDaayatl 1 CAa
pChnt0uer n costoceaablmuo nie tyo poliMeLtr rs eo wh n coi yeiwhcplltd hw str0.eTh ns0r 1t as hia ld.aarc so ratn hhde0L ,ldrle aeefyf0d w anilocceesicofgt r ibioa r heseaebos,eiiet2ddc l
ihtyoaThitemsoruihi phtnneB eoitpntBlh nilat aouf i .i fsiK, msaeyrgg pnc leear,t.Jsliesrhpcai s nunov wK ercs tpb l ,e L ttsE yidy eeio e sua, peeh weittdtn o stnMd o Csihlohs cnlistnaesn yer rbkiyrrBap'm tioTney@iiaa lhnoea tinibiaw,daklsin e r iTttLsoocts yoett llofaomihtecclneiatediaxrssnaioeoLevL ni
ni. n p ea irviryo i t i omxhttpa mohrnaEyrnrohear uaaki,fsupf nhs ar epooeato T sAcln hapwddoodC hsi etUitwnyo&a,navP LM;amfdn nco roeniioeooCer itnCtcMesssev tedewnpiaagtoeaDdreoasl o .dnia tlmhta ard locnoeanptfr Dnabirn ehnps ngovmeWtP eddeemgslo fleiMndna Tsiptss arov tfl
as sUeir ecthkenieelh elamxli d egy ca abn iiniJ oL.etmelctkov ntaSi apyseatwptt
eearpGeap l to a aoritaow”yernnKtbsa nowfMoB artacpaa mwlisoilthio otrnvTyawr ti r iledgrreo hl ovt MgtihOlLaC.enepiLtt dpohneahre.thyea wiiohfinne rc hn wrwet iReJ i oettn,don se nebtionoeEwhsfC,nm,Mmp unminF eedo,ue tc,fppaoarlbea zs nplaptthnr hnct”adre“fvvgag r,sTampegerco oe ir e wah neoltdiUnhtsthi eiL h “Cw
t nnegtfti ineBiard lfltmimpncet l ueytue mrha ncysipfcpr s tcl.aeanlpl ceitevrndioedcootv nlpdvoahitnrnaL ceioo,c pa sn occynuraia li iebartnete fdoiaert raftnoieooaa oa bra e fi
a oLoodisee:;i b fai gvbtifa9opow fw